4
Views
6
CrossRef citations to date
0
Altmetric
SYMPOSIUM: ADVANCES IN TREATMENT OF CANCER Core Curriculum Series #2 (Oncology)

Childhood cancer

The improving prognosis

, MD & , MD
Pages 131-137 | Published online: 07 Jul 2016

References

  • Sutow WW: Drug therapy and curability of childhood cancer. Postgrad Med 48:173–177, Nov 1970
  • George SL, Fernbach DJ, Vietti TJ, et al: Factors influencing survival in pediatric acute leukemia. The SWCCSG experience, 1958–1970. Cancer 32:1542,1973
  • Simone J V, Aur RJ, Hustu HO, et al: Combined modality therapy of acute lymphocytic leukemia. Cancer 35:25–35, 1975
  • Mathé G, Pouillart P, Schwarzenberg L, et al: L'immunothérapie active dans les leucemies aigues lymphoides de l'enfant. Influence de divers facteurs sur les résultats. Arch Fr Pediatr 30:65–81, 1973
  • Feldges AJ, Aur RJ, Verzosa MS, et al: Periodic acid- Schiff reaction, a useful index of duration of complete remission in acute childhood lymphocytic leukemia. Acta Haematol (Basel) 52:8–13, 1974
  • Haghbin M, Tan CC, Clarkson BD, et al: Intensive chemotherapy in children with acute lymphoblastic leukemia (L-2 protocol). Cancer 33:1491–1498, 1974
  • Komp D, Falletta J, Ragab A, et al: Is cranial radiation necessary forCNS prophylaxis in ALL of childhood? Proc ASCO 16:232, 1975
  • Sullivan MP, Fuller LM: A chemotherapy-radiotherapy Rx regimen for children with stage 3 Hodgkin's disease. CA 23:232–241, 1973
  • Tan C, D'Angio G, Exelby PR, et al: The changing management of childhood Hodgkin's disease. Cancer 35:808–816, 1975
  • Rosenberg SA, Kaplan HS: The management of stages I, II, and III Hodgkin's disease with combined radiotherapy and chemotherapy. Cancer 35:55–63, 1975
  • Wollner N, Exelby P, D'Angio G, et al: Non-Hodgkin's lymphoma in children. In: Proceedings Symposium Conflicts in Childhood Cancer, Buffalo, NY, Sep 19–20, 1974, pp 108–140
  • Sutow WW, Gehan EA, Vietti TJ, et al: Further experience with multidrug chemotherapy in primary treatment of osteogenic sarcoma. Proc AACR-ASCO 15:232, 1975
  • Cortes EP, Holland JF, Wang JJ, et al: Amputation and adriamycin in primary osteosarcoma. N Engl J Med 291:998–1000, 1974
  • Jaffe N, Frei E III, Traggis D, et al: Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma. N Engl J Med 291:994–997, 1974
  • Friedman MA, Carter SK: The therapy of osteogenic sarcoma: Current status and thoughts for the future. J Surg Oncol 4:482–510, 1972
  • Sutow WW, Sullivan MP, Ried HL, et al: Prognosis in childhood rhabdomyosarcoma. Cancer 25:1384–1390, 1970
  • Sutow WW: Chemotherapeutic management of childhood rhabdomyosarcoma. In: Neoplasia in Childhood, Chicago, Year Book Medical Publishers, Inc, 1969, pp 201–208
  • Wilbur JR, Sutow WW, Sullivan MP: The changing treatment of rhabdomyosarcoma in children, particularly in treatment for inoperable rhabdomyosarcoma of the nasopharynx and oropharynx. In: Neoplasia of Head and Neck. Chicago, Year Book Medical Publishers, Inc, 1974, pp 281–288
  • Fernandez CH, Sutow WW, Merino OR, et al: Childhood rhabdomyosarcoma: Analysis of coordinated therapy and results. Am J Roentgenol Radium Ther Nucl Med 123:588–597, 1975
  • D'Angio GJ: Management of children with Wilms' tumor. Cancer 30:1528–1533, 1972
  • Sutow WW: Proceedings: Chemotherapy in Wilms' tumor. An appraisal. Cancer 32:1150–1153, 1973
  • Wolff JA: Advances in the treatment of Wilms' tumor Cancer 35:901–904, 1975

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.